Home | Cardiovascular Business

Bartley P. Griffith, MD, and David Bennett. Image courtesy of UMMC.

Doctors involved with the historic procedure shared key details about their experience in the New England Journal of Medicine.

Read more about New details on the pig heart transplant patient's death, from the doctors who treated him

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Image courtesy of Apple.

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions.

Read more about Regulatory Roundup: FDA clears several new solutions, including Apple’s latest AFib offering

COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.

A Hong Kong study examined incidence rate ratios for major adverse cardiovascular events in the 27 days following each vaccine dose.

Read more about New data highlights the continued importance of COVID-19 vaccines for CVD patients

Two examples of new left atrial appendage occluders (LAAO), the Conformal omn left and the Laminar on the right. evi Nair, MD, FACC, FHRS, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit. #TVT #TVT2020 #LAA #LAAO #EPeeps

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

Read more about VIDEO: Advances in left atrial appendage occlusion technology

The Society for Cardiovascular Angiography and Interventions (SCAI) has responded to the U.S. Food and Drug Administration’s (FDA’s) recommendation that all infants and young children who receive iodinated contrast media (ICM) undergo thyroid testing. The group pushed back against this proposal, emphasizing that implementation would have “far-reaching consequences.”

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties.

Read more about Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

Azeem Latib explains advances in transcatheter mitral and tricuspid valve therapies at TVT 2022. #TVT #TVT22 #TVT2022 #TMVR #TTVR

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

Read more about VIDEO: Transcatheter tricuspid devices likely to gain FDA clearance before new mitral advances

The American Medical Association (AMA) has declared climate change as a major healthcare emergency. Sunrises and sunsets have become increasingly red in recent years with additional particulate matter in the atmosphere from larger, massive wild fires. Photo by Dave Fornell

A new study to examine the relationship between extreme-heat events and cardiovascular mortality found that the hottest days can indeed be deadly.

Read more about Killer heat: How climate change could lead to more cardiovascular deaths

The Boston Scientific Acurate neo2,. Abbott Portico and the new Edwards Sapien X4 TAVR valves were hot topics of discussion at TCT 2022. #TVT #TVT22 #TVT2022

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care.

Read more about VIDEO: TAVR's long-term impact on patient care

This latest recall involves the device's batteries, which are separating due to a "welding defect."

Read more about FDA announces another recall for troubled heart device after a patient death

A Medtronic Evolut Corevalve TAVR valve in use at Emory.

Here are links to more information for all the late-breaking presentations at the 2022 Transcatheter Valve Therapies (TVT) Structural Heart Summit.

Read more about Links to all the late-breaking structural heart studies at TVT 2022